AVIDITY BIOSCIENCES INC (RNA) Stock Income Statement
NASDAQ:RNA - Nasdaq - US05370A1088 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 8.93M | 10.90M | 9.56M | 9.22M | 9.33M | |||
| Operating Expenses | 442.19M | 389.83M | 245.16M | 188.14M | 127.38M | |||
| Research and Development | 336.25M | 303.59M | 190.97M | 150.40M | 101.18M | |||
| Selling, General, and Administrative Expenses | 105.94M | 86.24M | 54.19M | 37.73M | 26.20M | |||
| Operating Income | -433.27M | -378.94M | -235.60M | -178.91M | -118.05M | |||
| Interest Income/Expense | 64.63M | 56.88M | 23.97M | 4.98M | 100.00K | |||
| Other Income/Expense | -582.00K | -248.00K | -594.00K | -60.00K | -60.00K | |||
| Income Before Taxes | -369.22M | -322.30M | -212.22M | -174.00M | -118.01M | |||
| Income Tax | N/A | 0.00 | N/A | N/A | N/A | |||
| Net Income | -369.22M | -322.30M | -212.22M | -174.00M | -118.01M | |||
| EBITDA | -430.35M | -376.16M | -233.50M | -177.52M | -117.41M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.00 | -2.89 | -2.91 | -3.34 | -2.85 | |||
| Non GAAP EPS | -3.00 | -2.89 | -2.90 | -3.33 | -2.84 | |||
| Statistics | ||||||||
| Profit Margin | -4136.00% | -2957.71% | -2219.87% | -1887.20% | -1264.84% | |||
| Operating Profit Margin | -4853.44% | -3477.43% | -2464.41% | -1940.46% | -1265.27% | |||
All data in USD